Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 3
2019 3
2020 2
2021 3
2022 5
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Significance of Raynaud Phenomenon in Systemic Lupus Erythematosus.
Barbacki A, Rached-d'Astous N, Pineau CA, Vinet E, Grenier LP, Kalache F, Fallavollita S, Lukusa L, Bernatsky S. Barbacki A, et al. Among authors: fallavollita s. J Clin Rheumatol. 2022 Mar 1;28(2):e488-e490. doi: 10.1097/RHU.0000000000001773. J Clin Rheumatol. 2022. PMID: 35192594
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study.
Haraoui B, Khraishi M, Choquette D, Lisnevskaia L, Teo M, Kinch C, Galos C, Roy P, Gruben D, Woolcott JC, Vaillancourt J, Sampalis JS, Keystone EC; Canadian Tofacitinib for Rheumatoid Arthritis Observational Investigators. Haraoui B, et al. Arthritis Care Res (Hoboken). 2023 Feb;75(2):240-251. doi: 10.1002/acr.24966. Epub 2022 Oct 10. Arthritis Care Res (Hoboken). 2023. PMID: 35678771 Free PMC article.
Risk factors for prevalent and incident hypertension in rheumatoid arthritis: data from the Canadian Early Arthritis Cohort.
Hadwen B, Stranges S, Pope JE, Bartlett S, Boire G, Bessette L, Hitchon CA, Hazlewood G, Keystone EC, Schieir O, Thorne C, Tin D, Valois MF, Bykerk V, Barra L; CATCH Investigators. Hadwen B, et al. Rheumatol Adv Pract. 2024 May 22;8(2):rkae066. doi: 10.1093/rap/rkae066. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 38895593 Free PMC article.
Treatment Strategies in Early Rheumatoid Arthritis Methotrexate Management: Results From a Prospective Cohort.
Moura CS, Schieir O, Valois MF, Thorne C, Bartlett SJ, Pope JE, Hitchon CA, Boire G, Haraoui B, Hazlewood GS, Keystone EC, Tin D, Bykerk VP, Bernatsky S; Canadian Early Arthritis Cohort Investigators. Moura CS, et al. Arthritis Care Res (Hoboken). 2020 Aug;72(8):1104-1111. doi: 10.1002/acr.23927. Epub 2020 Jul 5. Arthritis Care Res (Hoboken). 2020. PMID: 31112011
Immune-Mediated Necrotizing Myopathy and Dietary Sources of Statins.
Barbacki A, Fallavollita SA, Karamchandani J, Hudson M. Barbacki A, et al. Among authors: fallavollita sa. Ann Intern Med. 2018 Jun 19;168(12):893-904. doi: 10.7326/L17-0620. Epub 2018 Feb 20. Ann Intern Med. 2018. PMID: 29459987 No abstract available.
"From Where I Stand": using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ).
Bartlett SJ, Bykerk VP, Schieir O, Valois MF, Pope JE, Boire G, Hitchon C, Hazlewood G, Bessette L, Keystone E, Thorne C, Tin D, Bingham CO 3rd; CATCH Investigators. Bartlett SJ, et al. Qual Life Res. 2023 May;32(5):1307-1318. doi: 10.1007/s11136-022-03227-7. Epub 2022 Sep 8. Qual Life Res. 2023. PMID: 36074252
14 results